BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2616636)

  • 1. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
    Eisen A
    Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
    [No Abstract]   [Full Text] [Related]  

  • 2. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
    Fava M; Rosenbaum JF; McGrath PJ; Stewart JW; Amsterdam JD; Quitkin FM
    Am J Psychiatry; 1994 Sep; 151(9):1372-4. PubMed ID: 8067495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC; Price LH
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoxetine-tricyclic combinations.
    Zelwer A
    Aust N Z J Psychiatry; 1993 Jun; 27(2):350, 352. PubMed ID: 8363551
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequence of drug administration in lithium augmentation: a case study.
    Price LH; Delgado PL; Charney DS; Heninger GR
    J Clin Psychiatry; 1988 Apr; 49(4):161-2. PubMed ID: 3356674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and cyclosporine in organ transplantation. Failure to detect significant drug interactions or adverse clinical events in depressed organ recipients.
    Strouse TB; Fairbanks LA; Skotzko CE; Fawzy FI
    Psychosomatics; 1996; 37(1):23-30. PubMed ID: 8600490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined fluoxetine and desipramine in resistant depression.
    Horgan D
    Aust N Z J Psychiatry; 1993 Mar; 27(1):166, 168. PubMed ID: 8481163
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
    Tiffon L; Coplan JD; Papp LA; Gorman JM
    J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of TCAs and SSRIs in the treatment of major depression in hospitalized geriatric patients.
    Miller FT; Freilicher J
    J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):173-6. PubMed ID: 7576042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing rapid metabolizers of antidepressants.
    Kraus RP; Diaz P; McEachran A
    Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidality and fluoxetine: is there a relationship?
    Fava M; Rosenbaum JF
    J Clin Psychiatry; 1991 Mar; 52(3):108-11. PubMed ID: 2005073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of fluoxetine in geriatric depression.
    Feighner JP; Boyer WF; Meredith CH; Hendrickson G
    Br J Psychiatry Suppl; 1988 Sep; (3):105-8. PubMed ID: 3074861
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
    Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
    J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A; Fontaine R; Elie R
    Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
    Fontaine R; Ontiveros A; Elie R; Vézina M
    Biol Psychiatry; 1991 May; 29(9):946-8. PubMed ID: 1904782
    [No Abstract]   [Full Text] [Related]  

  • 20. Prior antidepressant treatment does not have an impact on response to desipramine treatment in major depression.
    Young LT; Cooke RG; Levitt AJ; Joffe RT
    Biol Psychiatry; 1995 Sep; 38(6):410-2. PubMed ID: 8547462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.